KAELYNN FRANCISCO: Open Payments
NPI 1073382446 · MARRERO, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$591 in 28 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $539 · 2025 $591
Food & beverage: $591
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 5 | $110 |
| ABBVIE INC. | 4 | $77 |
| Merck Sharp & Dohme LLC | 2 | $48 |
| Janssen Biotech, Inc. | 2 | $44 |
| PharmaEssentia USA Corporation | 1 | $32 |
| ABIOMED | 1 | $30 |
| Regeneron Healthcare Solutions, Inc. | 1 | $29 |
| Dexcom, Inc. | 1 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $23 |
Products named: JEMPERLI, ELAHERE, BESREMI, KEYTRUDA QLEX, EVKEEZA, RYBREVANT, Dexcom G6 Transmitter, NINLARO.
Industry payments across LA — which companies pay providers there.
